Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Activated clotting time as a screening test prior to catheter-based cardiovascular procedures
Autore:
Siskin, GP; Reiner, E; Stainken, BF; Dowling, K; Dolen, EG; Quarfordt, S; Albons, G;
Indirizzi:
Albany Med Ctr, Inst Vasc Hlth 7 Dis, Albany, NY 12208 USA Albany Med CtrAlbany NY USA 12208 Vasc Hlth 7 Dis, Albany, NY 12208 USA Univ Maryland Med, Div Vasc & Intervent Radiol, Baltimore, MD USA Univ Maryland Med Baltimore MD USA & Intervent Radiol, Baltimore, MD USA
Titolo Testata:
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
fascicolo: 2, volume: 54, anno: 2001,
pagine: 191 - 195
SICI:
1522-1946(200110)54:2<191:ACTAAS>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
PARTIAL THROMBOPLASTIN TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; INTERVENTIONAL PROCEDURES; COAGULATION TIME; HEPARIN-THERAPY; ANTICOAGULATION; COMPLICATIONS; ACT;
Keywords:
angiography; coagulation; catheterization;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
35
Recensione:
Indirizzi per estratti:
Indirizzo: Siskin, GP Albany Med Ctr, Inst Vasc Hlth 7 Dis, MC-157,47 New Scotland Ave, Albany, NY 12208 USA Albany Med Ctr MC-157,47 New Scotland Ave Albany NYUSA 12208 A
Citazione:
G.P. Siskin et al., "Activated clotting time as a screening test prior to catheter-based cardiovascular procedures", CATHET C IN, 54(2), 2001, pp. 191-195

Abstract

The activated clotting time (ACT) was investigated as a rapid, inexpensive, point-of-service screening test for coagulation abnormalities prior to catheter-based procedures. A total of 963 patients were screened by obtaininga history, standard coagulation profile, and activated coagulation time. The prevalence of normal patients (normal ACT and coagulation profile) was 94% (sensitivity = 91%; specificity = 27%). A normal ACT had a positive predictive value of 95%. The ACT was an acceptable screening test due to its ability to predict positively a low rate of bleeding complication and normal coagulation studies. Patients with ACT > 150 sec should be further evaluated with a screening coagulation panel. Additionally, given its low specificity, coagulation studies should be obtained in high-risk patients since an abnormal ACT does not effectively correlate with abnormal coagulation studies. (C) 2001 Wiley-Liss, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/20 alle ore 16:08:44